All articles by Sarah Houlton – Page 2
-
BusinessSearching for more sustainable resin materials
Paul Jones of Bitrez is the 2021 Chemistry World Entrepreneur of the Year
-
ArticleSustainable safety testing
Unilever has been researching and applying alternatives to animal testing, and working with industry, academia, government scientists and NGOs to usher in a new era of sustainable safety testing that isn’t reliant on animal models.
-
ArticleA biodegradable future
By investing in research, working with its partners across its supply chain, and considering the entire product lifecycle, Unilever is making a biodegradable future obtainable
-
BusinessPharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
BusinessAstraZeneca to buy rare disease drugmaker Alexion in $39bn deal
Transaction would be the largest in AstraZeneca’s history
-
ResearchHow to solve a ‘nasty’ compound’s structure with a million-Euro synchrotron
Chemists overcomes challenges of handling explosive and toxic nitrogen to investigate its structure using Germany’s most expensive x-ray source
-
BusinessCovid-19 highlights need to update pharma supply chains
Resilience and redundancy are key amid protectionist calls for domestic manufacturing
-
BusinessThis little Crispr went to market
Gene editing technology heading towards commercial reality in pharmaceuticals, food and organ transplant
-
BusinessCancer and rare diseases dominated 2019 drug approvals
More streamlined review processes and changing R&D priorities have contributed to sustained increase in new medicines
-
BusinessPharmaceuticals roundup 2019
Under the shadow of political turmoil and major lawsuits, the industry returned to its strengths – making new drugs, and finding new ways to do it better
-
BusinessSixth in a line of Alzheimer’s drugs fails in trials
Treatments designed to stop amyloid peptide formation all seem to cause cognitive impairment rather than prevent it
-
BusinessLandmark ruling in Oklahoma opioid lawsuit
J&J judged responsible for ‘public nuisance’ in first case to go to trial
-
BusinessEnhancing solvents' sustainability
Increased recycling and replacing toxic solvents with greener alternatives will reduce environmental impact
-
BusinessCurbing industry’s carbon emissions
Replacing fossil-fuelled furnaces with renewable electrical heating and cutting carbon from some heavy industries could make a serious dent in climate targets
-
BusinessAbbVie to acquire Allergan in multibillion-dollar merger
Takeover deal will create world’s fifth-largest pharma company
-
BusinessEmerging from the US opioid crisis
With litigation against suppliers in full swing, how does the US counter its addiction to powerful painkillers?
-
BusinessUK government sets out antimicrobial resistance plan
Aims to cut antibiotic use and explore financial incentives for pharmaceutical companies
-
BusinessPharmaceuticals roundup 2018
Merger deals, product approvals and infrastructure changes have been overshadowed by political uncertainty, in Europe and around the world
-
BusinessCancer immunotherapy spreads rapidly
New approvals and expanded use for checkpoint inhibitor drugs illustrate the power of Nobel-winning science
-
BusinessCleaning up clinical trials
Campaigns to enforce complete and correct reporting of trial data are beginning to take hold